Table 5.
Selected Treatment-Related Late Adverse Events (n=74)
| CTCAE category | Grade 2 | Grade 3 | Grade 4 | |||
|---|---|---|---|---|---|---|
| CTCAE term | n | % | n | % | n | % |
| Maximum | 36 | 48.6 | 6 | 8.1 | 2 | 2.7 |
|
| ||||||
| Blood/bone marrow | ||||||
|
| ||||||
| Lymphopenia | 0 | 0.0 | 1 | 1.4 | 0 | 0.0 |
|
| ||||||
| Infection | ||||||
|
| ||||||
| Sepsis [with normal or Grade 1–2 ANC] | 0 | 0.0 | 1 | 1.4 | 0 | 0.0 |
| Skin infection [with normal or Grade 1–2 ANC] | 0 | 0.0 | 1 | 1.4 | 0 | 0.0 |
| Urinary tract infection [with unknown ANC] | 1 | 1.4 | 0 | 0.0 | 0 | 0.0 |
|
| ||||||
| Pain | ||||||
|
| ||||||
| Pain [not otherwise specified] | 0 | 0.0 | 1 | 1.4 | 0 | 0.0 |
|
| ||||||
| Gastrointestinal | ||||||
|
| ||||||
| Proctitis | 2 | 2.7 | 0 | 0.0 | 0 | 0.0 |
|
| ||||||
| Renal/genitourinary | ||||||
|
| ||||||
| Cystitis | 2 | 2.7 | 1 | 1.4 | 0 | 0.0 |
| Ureteric obstruction | 0 | 0.0 | 2 | 2.7 | 0 | 0.0 |
| Urinary frequency | 6 | 8.1 | 0 | 0.0 | 0 | 0.0 |
| Urinary incontinence | 16 | 21.6 | 0 | 0.0 | 2 | 2.7 |
CTCAE: Common Terminology Criteria for Adverse Events, version 3.0.
ANC: absolute neutrophil count.